A study found that new monoclonal antibody drugs for Alzheimer’s may slow cognitive impairment through boosting levels of a specific protein in the brain.
Boosting brain protein levels may slow decline from Alzheimer’s
- Post author:
- Post published:September 11, 2024
- Post category:News Feed
- Post comments:0 Comments